| Company Name: | Accuray, Inc. | | Ticker Symbol: | ARAY | | | WWW Address: | www.accuray.com |
| CEO: | Mr. Joshua H. Levine | | No. of Employees: | 1,100 |
| Common Issue Type: | CS | | Business Description: | Accuray, Inc. designs, develops and sells the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors anywhere in the body.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 5.26 |  0.11 | 4.55 | 5.51 | 5.16 | 5.28 | 5.05 | 818098 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 389.8 | 74.1 | 1.08 | -1.02 | 0.00 | 0.0 | 0.0 | 7.44 - 3.76 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 5.26 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 389.8 | mil |
| Latest Shares Outstanding | 74.1 | mil |
| Earnings pS (EPS) | -1.02 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 372,021 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 55.1 | mil |
| Float as % of Shares Outstanding | 76.5 | % |
| Foreign Sales | 220 | mil |
| Domestic Sales | 189 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 35.40 | % |
| Research & Devlopment (R&D) as % of Revenue | 22.90 | % |
| Gross Profit Margin | 41.6 | % |
| EBITDA Margin | -16.7 | % |
| Pre-Tax Profit Margin | -33.9 | % |
| Assets Turnover | 0.7 | % |
| Return on Assets (ROA) | -12.1 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -18.9 | % |
| Current Ratio | 2.2 | |
| Leverage Ratio (Assets/Equity) | 4.1 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 1.62 | |
| LT Debt/Total Capital | 62.0 | % |
| Working Capital pS | 2.56 | $ |
| Cash pS | 2.45 | $ |
| Book-Value pS | 1.65 | $ |
| Tangible Book-Value pS | 0.39 | $ |
| Cash Flow pS | -0.39 | $ |
| Free Cash Flow pS | -1.16 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.19 | |
| Price/Tangible Book Ratio | 13.64 | |
| Price/Cash Flow | -13.3 | |
| Price/Free Cash Flow | -4.5 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 4.8 | 103 | 13,083 | 45,472 |
| 4 Weeks | 5.41 | 4.07 | 4.25 | 23.8 | 116 | 9,874 | 197,475 |
| 13 Weeks | 5.41 | 3.76 | 4.59 | 14.6 | 105 | 10,826 | 682,067 |
| 26 Weeks | 6.87 | 3.76 | 6.29 | -16.4 | 68 | 11,451 | 1,419,957 |
| 52 Weeks | 7.44 | 3.76 | 5.95 | -11.6 | 69 | 8,314 | 2,070,076 |
| YTD | 6.83 | 3.76 | - | -18.2 | 70 | 13,584 | 1,290,437 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 5.24 | 5.03 | 4.63 | 5.35 | 5.69 | 1.08 | 1.22 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 11.50 | 59.5 | 18.93 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 36.41 | NA | 79.28 |
| R&D | 21.82 | NA | 36.13 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -25.1 | -30.7 | 84.1 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | -0.43 | -0.21 | -0.58 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 30.03 |
| Current Ratio | 1.8 |
| Quick Ratio (Acid Test) | 1.2 |
| Liquidity Ratio (Cash) | 0.83 |
| Receivables Turnover | 6.3 |
| Average Collection Period | 57 |
| Working Capital/Equity | 72.6 |
| Working Capital pS | 1.98 |
| Cash-Flow pS | 0.45 |
| Free Cash-Flow pS | -0.70 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.63 |
| Financial Leverage Ratio (Assets/Equity) | 2.4 |
| Debt Ratio | 58.7 |
| Total Debt/Equity (Gearing Ratio) | 0.41 |
| LT Debt/Equity | 0.41 |
| LT Debt/Capital Invested | 37.6 |
| LT Debt/Total Liabilities | 28.6 |
| Interest Cover | 1.3 |
| Interest/Capital Invested | 2.61 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.93 |
| Tobin's Q Ratio | 0.82 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -17.18 |
| Enterprise Value (EV)/Free Cash Flow | -12.97 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 13.64 |
| Price/Book Ratio - LTM | 3.19 |
| Price/Cash Flow Ratio | -13.3 |
| Price/Free Cash Flow Ratio - LTM | -4.5 |
| Price/Sales Ratio | 1.18 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 1.11 |
| Current Liabilities pS | 2.42 |
| Tangible Book Value pS - LTM | 0.39 |
| Book Value pS - LTM | 1.65 |
| Capital Invested pS | 3.71 |
| Cash pS - LTM | 2.45 |
| Cash Flow pS - LTM | -0.39 |
| Free Cash Flow pS - LTM | -1.16 |
| Earnings pS (EPS) | -1.02 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -12.32 |
| Free Cash Flow Margin 5YEAR AVG | -12.19 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | 0.5 |
| Equity Productivity | 2.09 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.7 |
| Capital Invested Productivity | 1.49 |
| Return on Capital Invested (ROCI) | 0.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 0.6 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 0.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.3 |
| Gross Profit Margin | 41.6 |
| Gross Profit Margin - 5YEAR AVRG. | 48.8 |
| EBITDA Margin - LTM | -16.7 |
| EBIT Margin - LTM | -31.5 |
| Pre-Tax Profit Margin | -18.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -7.1 |
| Effective Tax Rate | -3.4 |
| Effective Tax Rate - 5YEAR AVRG. | 2.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 195 |
| Revenue per Employee | 372,021 |
| Net Income per Employee | |
| Average Collection Period | 60 |
| Receivables Turnover | 6.3 |
| Day's Inventory Turnover Ratio | 135 |
| Inventory Turnover | 2.7 |
| Inventory/Sales | 20.0 |
| Accounts Payble/Sales | 4.45 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 2.88 |
| Fixed Assets Turnover | 2.61 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 2.85 |
| Revenue per $ Plant | 10.92 |
| Revenue per $ Common Equity | 2.09 |
| Revenue per $ Capital Invested | 1.49 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 27.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 33.4 |
| Research & Devlopment (R&D) as % of Revenue | 21.3 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 21.3 |
|
|  
|
| |
 |  |
